Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cocrystal Pharma Inc COCP

Healthcare
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company. The Company is engaged in discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), noroviruses and hepatitis C viruses (HCV). It is developing small molecule antiviral therapeutics that inhibit the essential viral replication function... see more

Recent & Breaking News (NDAQ:COCP)

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cocrystal Pharma, Inc. f/k/a BioZone - COCP

GlobeNewswire October 26, 2018

SHAREHOLDER ALERT: LCI CBS QRTEA USAT COCP ALNY CHGG JT DY: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

GlobeNewswire October 26, 2018

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Cocrystal Pharma, Inc. f/k/a/ BioZone Pharmaceuticals, Inc. (COCP) and Lead Plaintiff Deadline – November 19, 2018

GlobeNewswire October 26, 2018

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of LCI, TGTX and SFIX

GlobeNewswire October 25, 2018

COCP ALERT: Rosen Law Firm Reminds Cocrystal Pharma, Inc. Investors of Important Deadline in First Filed Case – COCP

GlobeNewswire October 24, 2018

Cocrystal Pharma, Inc. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey against Cocrystal Pharma, Inc. (f/k

GlobeNewswire October 24, 2018

SHAREHOLDER ALERT: AMPE LCI PZZA SKX PM USAT COCP: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

GlobeNewswire October 23, 2018

Scott+Scott Attorneys at Law LLP Reminds Investors of Securities Class Action Against USA Technologies, Inc. (USAT) and November 13 Lead Plaintiff Deadline

Business Wire October 23, 2018

CLASS ACTION UPDATE for COCP, TGTX and SFIX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

GlobeNewswire October 23, 2018

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Qurate, Fanhua, and Pretium and Encourages Investors to Contact the Firm

GlobeNewswire October 22, 2018

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CBS, COCP, TGTX and TRVN

GlobeNewswire October 22, 2018

SHAREHOLDER ALERT: AMPE NVRO PZZA OPK QRTEA MCHP COCP TGTX CPB TRVN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

GlobeNewswire October 21, 2018

COCP ALERT: Rosen Law Firm Files First Securities Class Action Lawsuit Against Cocrystal Pharma, Inc. – COCP (formerly known as BioZone Pharmaceuticals, Inc. - BZNE)

GlobeNewswire October 20, 2018

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LogMeIn, Inc. – LOGM

GlobeNewswire October 19, 2018

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 in Alnylam Pharmaceuticals, Inc. to Contact the Firm

Business Wire October 19, 2018

CLASS ACTION UPDATE for COCP and HAS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

GlobeNewswire October 17, 2018

SHAREHOLDER ALERT: PDD AMPE NVRO LCI CBS PZZA OPK QRTEA PVG COCP: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

GlobeNewswire October 17, 2018

COCRYSTAL PHARMA, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey against Cocrystal Pharma, Inc. (f/k

GlobeNewswire October 17, 2018

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CBS, PVG, COCP and ALNY

GlobeNewswire October 16, 2018

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Applied Optoelectronics, Inc. (AAOI) and Lead Plaintiff Deadline - November 30, 2018

PR Newswire October 16, 2018